Decentralized, Status Neutral, Stakeholder-engaged, Post-incarceration Intervention for People Living With and at Risk for HIV
Public ClinicalTrials.gov record NCT07927673. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
One out of six people with HIV (PWH) in the U.S. are incarcerated annually; two-thirds of individuals who are incarcerated meet criteria for substance use disorder (SUD) and many more in carceral settings have risk factors for HIV. Ending the U.S. HIV epidemic hinges on linking and engaging people with criminal legal system involvement (PCLSI) with HIV or related risk factors, especially those with SUDs, to optimize antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP) uptake and adherence. In this study, the investigator team will pursue Aim 1 (R33): Test the DEST2nation model in a multisite randomized control trial; and Aim 2 (R33): Estimate the cost of implementing and sustaining a decentralized, status neutral model and estimate its economic value from healthcare sector, state-policymaker, and societal perspectives.
Study identification
- NCT ID
- NCT07927673
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 420 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2026 (Estimated)
- Primary completion
- May 31, 2029 (Estimated)
- Completion
- May 31, 2029 (Estimated)
- Last update posted
- Nov 10, 2026
2026 – 2029
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Fortune Society | Long Island City | New York | 11101 | — |
| Philadelphia FIGHT | Philadelphia | Pennsylvania | 19107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07927673, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 10, 2026 · Synced Nov 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07927673 live on ClinicalTrials.gov.